In patients with AATD, there appears to be an increased risk of cytoplasmic antineutrophil cytoplasmic antibody (C-ANCA)-associated vasculitis, which is supported by plausible pathogenetic mechanisms. This evidence concerns the gene PRTN3 and vasculitis.